Collect. Czech. Chem. Commun.
2009, 74, 1161-1178
https://doi.org/10.1135/cccc2009040
Published online 2009-07-24 10:06:36
Cytostatic tetrazole–butenolide conjugates: linking tetrazole and butenolide rings via stille coupling and biological activity of the target substances
Vojtěch Balšáneka, Lucie Tichotováb, Jiří Kunešb, Marcel Špulákb, Milan Pourb,*, Ivan Votrubac and Vladimír Buchtad
a RE&D VUFB Ltd., Poděbradská 56/186, 180 66 Prague 9, Czech Republic
b Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 03 Hradec Králové, Czech Republic
c Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
d Department of Clinical Microbiology, University Hospital, Sokolská 581, 500 05 Hradec Králové, Czech Republic
References
1. Wermuth C. G.: The Practice of Medicinal Chemistry, 2nd ed., Part IV. Academic Press, London 2003.
2. Zh. Org. Khim. 1998, 34, 786.
J., Hrabálek A., Pour M., Pilař M., Waisser K., Odlerová Ž.:
3. Bioorg. Med. Chem. 2007, 15, 2898.
< J., Beckert R., Weiss D., Klimešová V., Waisser K., Möllmann U., Kaustová J., Buchta V.: https://doi.org/10.1016/j.bmc.2007.02.021>
4. Bioorg. Med. Chem. Lett. 2000, 10, 1893.
< M., Špulák M., Balšánek V., Kuneš J., Buchta V., Waisser K.: https://doi.org/10.1016/S0960-894X(00)00376-0>
5. J. Med. Chem. 2001, 44, 2701.
< M., Špulák M., Buchta V., Kubanová P., Vopršalová M., Wsól V., Fáková H., Koudelka P., Pourová H., Schiller R.: https://doi.org/10.1021/jm010155x>
6. Bioorg. Med. Chem. 2003, 11, 2843.
< M., Špulák M., Balšánek V., Kuneš J., Kubanová P., Buchta V.: https://doi.org/10.1016/S0968-0896(03)00220-7>
7. Antimicrob. Agents Chemother. 2004, 48, 873.
< V., Pour M., Kubanová P., Silva L., Votruba I., Vopršálová M., Schiller R., Fáková H., Špulák M.: https://doi.org/10.1128/AAC.48.3.873-878.2004>
8. Collect. Czech. Chem. Commun. 2001, 66, 1809.
< J., Balšánek V., Pour M., Buchta V.: https://doi.org/10.1135/cccc20011809>
9. Can. J. Chem. 1971, 49, 2139.
< R.: https://doi.org/10.1139/v71-346>
10. Chem. Heterocycl. Comp. 2002, 38, 183.
< A., Puš L., Baránek V., Kuneš J., Palát K.: https://doi.org/10.1023/A:1015387108748>
11. Prakt. Chem. 1929/1930, 124, 261.
< R., Henke-Stark F. J.: https://doi.org/10.1002/prac.19301240121>
12. J. Org. Chem. 1994, 59, 5905.
< V., Kapadia S., Krishnan B., Wang C., Liebeskind L. S.: https://doi.org/10.1021/jo00099a018>
13. J. Org. Chem. 1967, 32, 3580.
< J. C., Sheppard W. A.: https://doi.org/10.1021/jo01286a064>
14. J. Org. Chem. 1953, 18, 1183.
< C. R., Amstutz E. D.: https://doi.org/10.1021/jo50015a016>
15. Liebigs Ann. 1996, 1091.
A., Mori K.:
16. Khim. Geterotsikl. Soedin. Sb.: Azotsoderzhashchie Geterotsikly 1967, 199.
R. G., Panchenko V. D.:
17. Collect. Czech. Chem. Commun. 1997, 62, 510.
< H.-D., Odlerová Ž., Waisser K.: https://doi.org/10.1135/cccc19970510>
18. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard, NCCLS Document M27-A, 771 E. Lancaster Avenue, Villanova, PA 19085, 1997.
19. J. Med. Chem. 2000, 43, 1817.
< M., Holý A., Votruba I., Dvořáková H.: https://doi.org/10.1021/jm991167+>
20. Cancer Res. 1987, 47, 936.
J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B.:
21. Russ. J. Org. Chem. 1996, 32, 1194.
M. A., Koldobskii G. I.:
22. Arch. Pharm. 2005, 338, 385.
< J., Waisser K., Kuneš J., Kaustová J.: https://doi.org/10.1002/ardp.200400967>